Pharma major Dr Reddy’s Laboratories Ltd has launched Finasteride tablets, a bioequivalent generic version of Propecia (Finasteride) tablets in the US market. The tablets are used for treating male pattern hair loss.

Dr. Reddy’s Abbreivated New Drug Application (ANDA) for Finasteride has been awarded a 180-day period of marketing exclusivity in the US on January 2, 2013, the Hyderabad-based company said in a release.

The Propecia tablets brand had US sales of approximately $136 million for the most recent 12 months ended in October 2012, according to IMS Health.

(This article was published on January 3, 2013)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.